
CAS: 943764-99-6

Ref: IN-DA01EO4B
25mg | 157.00 € | ||
50mg | 264.00 € | ||
100mg | 597.00 € | ||
250mg | To inquire |
Estimated delivery in United States, on Tuesday 15 Apr 2025

4-(((1S,4S)-5-(4-(4-(Oxazol-2-Yl)Phenoxy)Benzyl)-2,5-Diazabicyclo[2.2.1]Heptan-2-Yl)Methyl)Benzoic Acid
CAS:943764-99-6
Purity:
99%
Molecular weight:
481.54g/mol
Ref: 54-OR1023929
1g | 1,909.00 € | ||
100mg | 469.00 € | ||
250mg | 780.00 € |
Estimated delivery in United States, on Wednesday 16 Apr 2025

Ref: 54-BUP13051
25mg | 225.00 € | ||
50mg | 342.00 € | ||
100mg | 507.00 € | ||
200mg | 697.00 € | ||
500mg | 1,274.00 € |
Estimated delivery in United States, on Wednesday 16 Apr 2025

Acebilustat
CAS:943764-99-6
Acebilustat (CTX-4430) (ZK322) is an effective and specific leukotriene B4 hydrolase inhibitor.
Formula:
C29H27N3O4
Purity:
99.47% - 99.59%
Color and Shape:
Solid
Molecular weight:
481.54
Ref: TM-T3715
2mg | 38.00 € | ||
5mg | 58.00 € | ||
10mg | 80.00 € | ||
25mg | 145.00 € | ||
50mg | 225.00 € | ||
100mg | 334.00 € | ||
200mg | 467.00 € | ||
1mL*10mM (DMSO) | 65.00 € |
Estimated delivery in United States, on Tuesday 22 Apr 2025

ACEBILUSTAT
CAS:943764-99-6
Purity:
95%
Molecular weight:
481.552001953125
- Ethers
- Tertiary Amines
- Mixed Heterocycles
- 5-membered Heterocycles
- See more categories
- 6-membered Heterocycles
- Benzoic Acids
- Amino Acids (AA)
- Aminoacids and derivatives
- Benzimidazole and Imidazole Derivatives
- Quinones and Derivatives
- Fatty Acids and Lypidic Derivatives
- Esters and Derivatives
- Ethers and Derivatives
Ref: 10-F841072
25mg | To inquire |
Estimated delivery in United States, on Friday 25 Apr 2025

Acebilustat
CAS:943764-99-6
Acebilustat is a new drug that has been developed to treat inflammatory diseases. It inhibits …
Formula:
C29H27N3O4
Purity:
Min. 95%
Molecular weight:
481.54 g/mol
Ref: 3D-TMB76499
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |